Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2023 …

HAYWARD, Calif.–(BUSINESS WIRE)–Feb 7, 2024–. Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on …

Do you trust this headline?

Based on recent headline ratings, 86% of this readership currently trusts the local media, which has an average score of 83% regionally and is currently trending positive.

86%

Media Trust Score86%